RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15

ADAPTHEALTH CORP

ADAPTHEALTH CORP

AHCO

0.00

RBC Capital analyst Ben Hendrix maintains AdaptHealth (NASDAQ: AHCO) with a Outperform and raises the price target from $13 to $15.